23 résultats
CCTG BR.31: Adjuvant durvalumab (D) in resected non-small-cell lung cancer (NSCLC): Final overall survival (OS) and minimal residual disease (MRD) analyses
Auteurs / Authors
G. Goss, G. Darling, V. Westeel, K. Nakagawa, B. Massuti Sureda, F. Perrone, S. McLachlan, J.H. Kang, Y. Wu, A.C. Dingemans, R. Dziadziuszko, M. Okada, L. Greillier, C. Audigier-Valette, S. Sugawara, E. Nadal, A. Catino, M.R. Stockler, K.U. Ding, C. O'Callaghan
Journal / Conference
ESMO
Année / Year
2025
PMID / session
Etude IFCT
Central pathology review of thymic tumors: updated analysis of diagnostic concordance in the French RYTHMIC cohort
Auteurs / Authors
Á. López Gutiérrez, L. Chalabreysse, J-P. Dales, R. Dubois, V. Hofman, A. Lupo Mansuet, A. de Muret, N. Piton, I. Rouquette, V. Secq, D. Sizaret, V. Thomas de Montpreville, A. Botticella, D. Miliziano, L. Zullo, P. Missy, J. Remon Masip, N. Girard, T. Molina, B. Besse
Journal / Conference
ESMO
Année / Year
2025
PMID / session
Etude IFCT
Efficacy of lorlatinib after failure of a first-line ROS1 tyrosine kinase inhibitor (ROS1 TKI) in patients (pts) with advanced ROS1-positive non-small cell lung cancer (ROS1+ NSCLC)
Auteurs / Authors
M. Duruisseaux, C. Ardin, C. Mascaux, F. Bigot, S. Cousin, F. Guisier, A. Rabeau, M.C. Willemin, M. Zysman, A.B. Cortot, I. Monnet, A. Swalduz, P-J. Souquet, A. Langlais, F. Morin, F. Escande, V. Westeel, D. Moro-Sibilot
Journal / Conference
ESMO
Année / Year
2025
PMID / session
Etude IFCT
SMARC4, c-MET and PD-L1 expression in pN2 non-small cell lung cancer from LungART IFCT 0503 trial
Auteurs / Authors
D. Diaz-Jimenez, V.M. Albarran Artahona, C. Le Pechoux, M.R. Ghigna, W. Zrafi, J. Adam, G. Granier, N. Cozic, L. Zullo, E. Bouvier, J-P. Dales, P. Abdayem, M. Frelaut, P. Lavaud, A. Botticella, F. Barlesi, D. Planchard, A. Levy, B. Besse, J. Remon Masip.
Journal / Conference
ESMO
Année / Year
2025
PMID / session
Etude IFCT
Paclitaxel-bevacizumab +/- atezolizumab in advanced non-squamous NSCLC progressing after chemo-immunotherapy: IFCT-2201 ADAPTABLE randomized phase II trial
Auteurs / Authors
E. Giroux-Leprieur; A. Scherpereel; L. Greillier; V. Gounant; S. Hiret; L. Bigay-Game; G. Pavaut; M. Zysman; C. Deldycke; E. Berton; S. Galland-Girodet; C. Guguen; C. Mascaux; S. Couraud; O. Bylicki; M. El Hajjam; P. Fournel; A. Langlais; F. Morin; V. Westeel.
Journal / Conference
ESMO
Année / Year
2025
PMID / session
Etude IFCT
The COALA (Cure Oncogene-Addicted Lung Adenocarcinoma) Network: A Nationwide Consortium to Improve Lung Cancer Outcome
Auteurs / Authors
J. Mazieres, V. Albinet, O. Calvayrac, M. Alifano, S. Benzekry, A. Cortot, D. Damotte, M. Duruisseaux, L. Fernandez-Cuesta, L. Friboulet, N. Girard, P. Hofman, A. Maraver, S. Ortiz-Cuaran, V. Pancaldi, A. Swalduz, E. Tartour, A. Vézian, V. Westeel, M. Wislez, G. Zalcman
Journal / Conference
WCLC
Année / Year
2025
PMID / session
Poster
Etude IFCT
Thymic Cancer in France: A Comprehensive Analysis of Incidence Based on French National Healthcare Data
Auteurs / Authors
Á. López Gutiérrez, A. Loliver, J.C. Benitez Montañez, J. Remon Masip, A. Rousseau, D. Planchard, F. Barlesi, P. Lavaud, M. Frelaut, A. Gazzah, C. Parisi, P. Abdayem, D. Miliziano, L. Zullo, V. Favorito, M. Gasparro, D. Diaz-Jimenez, N. Girard, V. Thomas de Montpreville, O. Mercier, P. Missy, S. Foulon, B. Besse
Journal / Conference
WCLC
Année / Year
2025
PMID / session
Etude IFCT
CCTG IND227, a Randomized Trial of Chemotherapy + Pembrolizumab in Advanced Pleural Mesothelioma: Updated Analyses
Auteurs / Authors
S. Laurie; Q. Chu; F. Perrone; L. Greillier; W. Tu; M.C. Piccirillo; F. Grosso; G. Lo Russo; M. Florescu; M. Mencoboni. A. Morabito; F.L. Cecere; G.L. Ceresoli; D.E. Dawe; P.A. Zucali; M. Pagano; J.R. Goffin; M.L. Sanchez; C. Gridelli; G. Zalcman; X. Quantin; V. Westeel; P. Gargiulo; S. Delfanti; D. Tu; C.W. Lee; N. Leighl; J. Sederias; P. Brown-Walker; Y. Luo; S. Lantuejoul; M-S. Tsao; A. Scherpereel; P. Bradbury; L. Seymour
Journal / Conference
WCLC
Année / Year
2025
PMID / session
Oral abstract
Etude IFCT
First-Line Atezolizumab Plus Chemotherapy in Elderly Patients With Advanced NSCLC, IFCT-1805 Elderly: A Randomized, Multicenter, Phase 3 Trial
Auteurs / Authors
C. Mascaux; L. Greillier; L. Moreau; T. Egenod; A-C. Toffart; J. Cadranel; A. Stancu; O. Molinier; M. Wislez; S. Fraboulet; E. Giroux-Leprieur; E. Pichon; L. Bigay-Game; N. Cloarec; S. Couraud; P. Masson; A. Langlais; F. Morin; E. Quoix; V. Westeel
Journal / Conference
WCLC
Année / Year
2025
PMID / session
Oral abstract
Etude IFCT
MiR-193b-3p and miR-132-3p as prognostic biomarkers of survival in pleural mesothelioma patients treated with first-line bevacizumab plus pemetrexed-platinum chemotherapy in the IFCT-0701 MAPS phase 3 trial
Auteurs / Authors
Piccirillo MC, Chu Q, Bradbury P, Tu W, Coschi CH, Grosso F, Florescu M, Mencoboni M, Goffin JR, Pagano M, Ciardiello F, Cecere FL, Vincent M, Ferrara R, Dawe DE, Hao D, Lee CW, Morabito A, Gridelli C, Cavanna L, Iqbal M, Blais N, Leighl NB, Wheatley-Price P, Tsao MS, Ugo F, El-Osta H, Gargiulo P, Gaudreau PO, Tu D, Sederias J, Brown-Walker P, Perrone F, Seymour L, Laurie SA
Journal / Conference
Journal of Thoracic Oncology
Année / Year
2025
PMID / session
Etude IFCT
Pathomics-based prediction of thymic epithelial tumor subtypes within the French RYTHMIC network.
Auteurs / Authors
L. Zullo
Journal / Conference
ASCO
Année / Year
2025
PMID / session
Etude IFCT
Molecular profiling and survival in oncogene-addicted resected stage IIIAN2 non-small cell lung cancer (NSCLC): A study from the Lung ART IFCT 0503 trial
Auteurs / Authors
Vi. Albarran-Artahona
Journal / Conference
ASCO
Année / Year
2025
PMID / session
Etude IFCT
An international, multicenter, prospective randomized trial of adjuvant chemotherapy for stage Ia-IIa non-small cell lung cancer identified as high-risk by a 14-gene molecular assay.
Auteurs / Authors
D. Spigel
Journal / Conference
ASCO
Année / Year
2025
PMID / session
Etude IFCT
Pathomics-based prediction of thymic epithelial tumor subtypes within the French RYTHMIC network
Auteurs / Authors
Lodovica Zullo, Mathilde Bateson, Jose Benitez-Montanez, Audrey Mansuet-Lupo, Damien Sizaret, Juan Florez-Arango, Alvaro Lopez-Gutierrez, Daniela Miliziano, Pascale Missy, Vincent De Montpreville, Olaf Mercier, Jordi Remon Masip, David Planchard, Nicolas Girard, Thierry Molina, Benjamin Besse
Journal / Conference
ASCO
Année / Year
2025
PMID / session
Etude IFCT
Molecular profiling and survival in oncogene-addicted resected stage IIIAN2 non-small cell lung cancer (NSCLC): A study from the Lung ART IFCT 0503 trial
Auteurs / Authors
Victor Albarran-Artahona, Benjamin Besse, Ludovic Lacroix, Wael Zrafi, Diego Díaz-Jiménez, Maria Rosa Ghigna, Guillaume Granier, Nathalie Cozic, Emilie Bouvier-Morel, Julien Adam, Cecile Le Pechoux, Antonin Levy
Journal / Conference
ASCO
Année / Year
2025
PMID / session
Etude IFCT
An international, multicenter, prospective randomized trial of adjuvant chemotherapy for stage Ia-IIa non-small cell lung cancer identified as high-risk by a 14-gene molecular assay
Auteurs / Authors
David Spigel, Virginie Westeel, Ian Anderson, Laurent Greillier, Florian Guisier, Olivier Bylicki, Firas Badin, Gaelle Rousseau-Bussac, Clotilde Deldycke, Frank Griesinger, Adam Bograd, Wangjian Zhong, Matthew Gubens, John Crowley, Heiko von der Leyen, Gavitt Woodard, Johannes Kratz, David Jablons, Michael Mann
Journal / Conference
ASCO
Année / Year
2025
PMID / session
Etude IFCT
Real World Data of everolimus in patients with Thymic epithelial tumors (TETs)
Auteurs / Authors
Á. López Gutié
rrez
, J.D. Florez Arango
, J.C. Benitez Montanez
,
D. Miliziano
, E. Dansin
, G. Giaccone
, C. Basse
, J. Mazieres
,
T. Pierret
, E. Pons-Tostivint
, J. Arrondeau, M. Aldea
,
D. Diaz Jimé
nez
, L. Zullo, F. Aboubakar, P. Missy,
J. Remon Masip, T. Molina, N. Girard, B. Besse
Journal / Conference
ELCC
Année / Year
2025
PMID / session
Etude IFCT
Real World Data of lenvatinib in patients with Thymic epithelial tumors (TETs)
Auteurs / Authors
Á. López Gutiérrez
, J.C. Benitez Montanez
, J.D. Florez Arango
,
D. Miliziano
, E. Dansin
, G. Giaccone
, C. Basse
, J. Mazieres
,T. Pierret
, E. Pons-Tostivint
, J. Arrondeau, M. Aldea,
D. Diaz Jiménez
, L. Zullo, F. Aboubakar, P. Missy,
J. Remon Masip, T. Molina, N. Girard, B. Besse
Journal / Conference
ELCC
Année / Year
2025
PMID / session
Etude IFCT
Predictors of long-term response and survival in patients with extensive stage small cell lung cancer (ES-SCLC) receiving atezolizumab plus chemotherapy in a real-world setting (IFCT-1905 CLINATEZO)
Auteurs / Authors
L. Falchero
, K. Amrane
, B. Godbert
, B. Leterre
, J. Madelaine
,P. Fournel
, C. Mascaux
, J. Raimbourg
, S. Schneider
, A. Swalduz,
R. Veillon, A. Langlais, P. Missy, F. Morin, V. Westeel,
N. Girard
Journal / Conference
ELCC
Année / Year
2025
PMID / session
Etude IFCT
Stratification of pleural mesothelioma patients for combined immunotherapy based on sarcomatoid component and tumour microenvironment markers in the IFCT-MAPS2 study
Auteurs / Authors
G. Tosato, Y. Blum, J-B. Assié, R. Sequeiros
, A. Langlais
,
M. Arnould
, F. Damiola
, E. Amour, C. Meiller
, M-C. Jaurand
,A. de Reynies
, V. Westeel
, J. Mazieres
, L. Greillier
, F. Morin
,S. Lantuejoul
, A. Scherpereel, G. Zalcman, D. Jean
Journal / Conference
ELCC
Année / Year
2025
PMID / session
Etude IFCT
Sites of relapse and subsequent therapy in the BR.31 phase 3 study of durvalumab vs placebo in resected stage IB-IIIA NSCLC
Auteurs / Authors
V. Westeel
, G. Goss
, G. Darling
, K. Nakagawa
, B. Massuti Sureda
,
F. Perrone
, S-A. McLachlan
, J.H. Kang
, Y-L. Wu
,A-M.C. Dingemans, R. Dziadziuszko, M. Okada, L. Greillier,
C. Audigier-Valette, F. Morin, S. Sugawara, E. Nadal,
M.R. Stockler, K. Ding, C. O’Callaghan
Journal / Conference
ELCC
Année / Year
2025
PMID / session
Etude IFCT
Real-world effectiveness and tolerability of sotorasib in patients with KRAS G12C-mutated metastatic non-small cell lung cancer: The IFCT-2102 Lung KG12Ci study
Auteurs / Authors
Wislez M, Mascaux C, Cadranel J, Thomas QD, Ricordel C, Swalduz A, Pichon E, Veillon R, Gounant V, Rousseau-Bussac G, Madroszyk A, Daniel C, Ravoire M, Metivier AC, Fournel P, Missy P, Morin F, Guisier F, Westeel V.
Journal / Conference
European Journal of Cancer
Année / Year
2025
PMID / session
Etude IFCT
Prognostic Value of FDG PET Metabolic Parameters Before and After 42 Gy of Radiochemotherapy in Patients with Inoperable Stage III Nonsmall Cell Lung Cancer
Auteurs / Authors
Vera P, Giraud P, Hapdey S, Gouel P, Jan O, Le Roux P, Langlais A, Lévêque E, Le Tinier F, Olivier A, Martin E, Berriolo-Riedinger A, Pourel N, Broglia JM, Boisselier P, Guillemard S, Salem N, Brenot-Rossi I, Garcia C, Berthold C, Giroux-Leprieur E, Moreau D, Guillerm S, Benali K, Tessonnier L, Audigier-Valette C, Lerouge D, Quak E, Massabeau C, Courbon F, Loo M, Larrouy A, Ghazzar N, Chaumet-Riffaud P, Amour E, Zalcman G, Modzelewski R, Thureau S.
Journal / Conference
Journal of Nuclear Medicine
Année / Year
2025
PMID / session
Etude IFCT